Silicon Canals
No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Community partners
    • Amsterdam
    • Rise by Techleap.nl
    • EOR handbook by Atlas HXM
    • Guest Contributions
    • Business Wire
    • Sign up for our newsletter!
  • Global Jobs
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Contribute your content
    • Team
    • About us
  • Partner with us
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Community partners
    • Amsterdam
    • Rise by Techleap.nl
    • EOR handbook by Atlas HXM
    • Guest Contributions
    • Business Wire
    • Sign up for our newsletter!
  • Global Jobs
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Contribute your content
    • Team
    • About us
  • Partner with us
No Result
View All Result
Silicon Canals
No Result
View All Result

UK’s Evonetix extends Series B with €22.3M to commercialise DNA synthesis platform

Vishal Singh by Vishal Singh
February 7, 2023
in (Crowd)funding, News
Evonetix

Evonetix founder, Matthew Hayes | Image credit: Evonetix

21
SHARES
LinkedInTwitterWhatsAppFacebook
Read this article in:

Cambridge-based Evonetix, a synthetic biology company that brings semiconductor technology to DNA synthesis, announced on Tuesday, February 7, that it has raised an additional $24M (approximately €22.36M) to bring its total Series B funding round to $54M.

The round was led by existing investor Foresite Capital. Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures, and Providence also participated in the round.

Jim Tananbaum, Founder and CEO at Foresite Capital, says, “We continue to be impressed by the Evonetix team and technology, and are excited to lead this round to accelerate their commercial strategy and make gene synthesis more accessible.”

“Reimagine Biology”

Founded in 2015 by Matthew Hayes and currently led by CEO Colin McCracken, Evonetix claims to reimage biology by developing a different approach to gene synthesis – a highly parallel desktop platform to synthesise DNA with better accuracy and scale.

- Partner content -
Atlas HXM EOR Employee of Record
How EOR is becoming a crucial tool in 2023
EOR gains importance as companies digitise and hire globally. Learn from industry leaders...Show More
EOR gains importance as companies digitise and hire globally. Learn from industry leaders using EOR with Atlas HXM.Show Less
Read more

The patented Binary Assembly method developed by Evonetix uses a silicon chip to manage the synthesis of DNA at thousands of separate thermally controlled reaction sites, or “pixels”, and their assembly into highly accurate long DNA on the chip surface.

The company says this method accelerates research in the field of synthetic biology by allowing the precise synthesis of thousands of sequences on a single chip to fulfil the need for complicated libraries and the assembly of lengthy DNA in days rather than weeks.

The Evonetix DNA writer will be a desktop platform that is accessible to all researchers. The company says this third-generation DNA synthesis technology will provide scalable, accurate DNA synthesis.

According to the company, it has the potential to revolutionise how this DNA is manufactured and supplied to consumers, boosting research in applications across medicine, biotech, food, agriculture, and data storage.

Capital utilisation

Evonetix says it will use the funds for the commercialisation of its semiconductor chips and to expand the gene assembly capabilities of its proprietary binary assembly technology.

Colin McCracken, CEO at Evonetix, says, “This substantial investment round demonstrates continued confidence in the progress of our technical development and its potential to revolutionise the accessibility of gene synthesis.”

“Evonetix is in a very exciting phase, having recently opened our early access programme. This investment will support us as we execute on our commercial strategy to put benchtop gene synthesis in the hands of users,” adds McCracken.

 - Partner content -
How to succesfully outsource…
How to succesfully outsource…
...your recruitment or product development with our curated community partners!
...your recruitment or product development with our curated community partners! Show Less
Read more
Tags: fundingnews
Share1Tweet5SendShare8

Partner with us | Download Media Kit

Thank you for visiting Silicon Canals! If you want to partner with us, look at our options.

Featured | Tech Events

Current Month

october, 2023

Silicon Canals | Jobs

Breaking news from Amsterdam | Partner

Invest-NL secures €350M in guarantees for Dutch sustainable ventures through InvestEU partnership: Know more

Looking for a job in Amsterdam? These unicorns are hiring currently hiring

Amsterdam’s hypeal.com raises €188K to reshape the way digital assets are utilised

Partner content | Work with us

Amsterdam-based startups that raised funding in September; some are hiring right now

Amsterdam’s Framer secures €25.5M to scale its no-code website building platform

Product Spotlight: Fairphone 5 with co-founder Miquel Ballester

  • About Silicon Canals
  • Partner with Silicon Canals
  • Impressum
  • Contact us
  • Sign up for our newsletter!
  • Disclaimer
  • Privacy Policy
  • Cookie Policy (UK)
  • Cookie Policy (EU)
  • Terms & Conditions Silicon Canals

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Community partners
    • Amsterdam
    • Rise by Techleap.nl
    • EOR handbook by Atlas HXM
    • Guest Contributions
    • Business Wire
    • Sign up for our newsletter!
  • Global Jobs
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Contribute your content
    • Team
    • About us
  • Partner with us

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

X
X